SANUWAVE Health, Inc. (OTCBB:SNWV) announced that it has entered into subscription agreement for gross proceeds of $1,000,000 on January 24, 2014. The company will issue 18% convertible promissory note in the transaction. The company will also issue 2,055,421 series A warrants and 1,233,252 series B warrants to the investors.

The notes have a term of nine months from issuance and are convertible into common shares of the company at a fixed conversion price of $0.55 per share. The transaction will include participation from selected accredited investors. The notes are unsecured.

Smith, Gambrell & Russell, LLP will act as legal advisor to the company. The company may prepay the note in cash, in whole but not in part, prior to the maturity date or the conversion of the note.